l-arginine, n2-((4-methylphenyl)sulfonyl)-, methyl ester
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 23, 2019 (NCT03953326)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- S-formylglutathione hydrolaseSUBSTRATE
ESD substrate
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03953326 | Phase 1/Phase 2 (Phase 2) | Apr 23, 2019 | Pennsylvania State University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pennsylvania State University | Academic/Hospital | 1 | 1 | 1 | 2019 |
1 organizations
Page 1 / 1